Supplementary Material
: Number of circulating tumor cells with ALK rearrangement per 1.88 mL of blood Abbreviations: ALK, anaplastic lymphoma kinase; HD, healthy donor; P, patient; NSCLC, non-small cell lung cancer.
Note: A positive ALK mutation is considered when there is a disruption of ALK gene resulting in patterns such as 1F1R1G, 1F1R, 2R2G, etc., but excludes the 1F1G pattern and its variants. *CTC count results based on 7.5 mL blood, not 1.88 mL. These data points have not included determining assay cut-off.
^CTC counts at subsequent time point after initiation of therapy/therapies, not including ALK TKI inhibitors. 
